|
⚲
|
| Keyboard |
| Gemayel Georges
✚
|
|
|---|---|
| CIK # | 0001256088 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001256088] | |
| 4 | [0001256088] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gemayel Georges | |
| Disc Medicine Inc | |
| Supernus Pharmaceuticals Inc | |
| Momenta Pharmaceuticals Inc | |
| Dimension Therapeutics Inc | |
| Horizon Pharmaceutical LLC | |
| NPS Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-06 | Option exercise | 7,905 | $25.30 | 199,996 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-06 | Sell | 8,787 | $53.00 | 465,711 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-03-06 | Option exercise | 7,905 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-05 | Sell | 10,000 | $53.71 | 537,100 |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-23 | Option exercise | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-23 | Option exercise | 15,000 | $12.98 | 194,700 |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 2,989 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 4,977 | $0.00 | |
|
Disc Medicine Inc IRON
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 10,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2025-02-22 | Disposed to issuer | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2025-02-19 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 7,296 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-08 | Sell | 10,787 | $36.30 | 391,568 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-11-08 | Option exercise | 10,787 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-08 | Option exercise | 10,787 | $11.46 | 123,619 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-11-07 | Option exercise | 14,213 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-07 | Option exercise | 14,213 | $11.46 | 162,881 |
| showing 20 of 104 most recent transactions | |||||